Gem citationer

Citação APA (7ª ed.)
Zheng, H., Qin, X., Zheng, Y., Yang, X., Tan, J., Cai, W., . . . Liao, H. (2024). Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: An updated systematic review and meta-analysis. Frontiers Media S.A.
Citação do estilo Chicago (17ª ed.)
Zheng, Haosheng, Xianyu Qin, Yuzhen Zheng, Xingping Yang, Jian Tan, Weijie Cai, Shiyun He, e Hongying Liao. Addition of Bevacizumab to EGFR Tyrosine Kinase Inhibitors in Advanced NSCLC: An Updated Systematic Review and Meta-analysis. Frontiers Media S.A, 2024.
Citação MLA (9ª ed.)
Zheng, Haosheng, et al. Addition of Bevacizumab to EGFR Tyrosine Kinase Inhibitors in Advanced NSCLC: An Updated Systematic Review and Meta-analysis. Frontiers Media S.A, 2024.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.